Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (S — BJORN E OSKARSSON (MAYO CLI
PROJECT SUMMARY/ABSTRACT Current treatment options for amyotrophic lateral sclerosis (ALS) are inadequate, and many patients living with ALS seek access to experimental therapies with the hope that th
| Project title | Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (S |
|---|---|
| Project number | 1U01NS136022-01A1 |
| PI name | BJORN E OSKARSSON |
| Institution | MAYO CLINIC JACKSONVILLE |
| Funding mechanism | U01 |
| Agency | NINDS |
| Award amount | $6.13M |
| Fiscal year | 2024 |
| Project start | 2024-09-01T00:00:00 |
| Project end | 2028-08-31T00:00:00 |
| Abstract | PROJECT SUMMARY/ABSTRACT Current treatment options for amyotrophic lateral sclerosis (ALS) are inadequate, and many patients living with ALS seek access to experimental therapies with the hope that th |
| Key terms | <ALS patients><ALS therapy><ALS treatment><Acceleration><Access to Care><Adherence><Age><Amyotrophic |
$799/mo
Try GrantRadar →